Tag: Mydecine - Psilocybin Alpha

Mydecine Innovations Group Offers Management and Clinical Trials Update

Mydecine Innovations Group Offers Management and Clinical Trials Update

Post published:November 17, 2020
Post category:Press Release

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

Post published:October 16, 2020
Post category:Press Release

Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

Post published:October 14, 2020
Post category:Press Release

Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin

Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin

Post published:October 7, 2020
Post category:Press Release

Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

Post published:September 30, 2020
Post category:Press Release

Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration

Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration

Post published:September 24, 2020
Post category:Press Release

Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management

Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management

Post published:September 17, 2020
Post category:Press Release

Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets

Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets

Post published:September 15, 2020
Post category:Press Release

Mydecine Innovations Group Announces Extended Lock-Up Arrangement

Mydecine Innovations Group Announces Extended Lock-Up Arrangement

Post published:August 25, 2020
Post category:Press Release

Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise

Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise

Post published:August 18, 2020
Post category:Press Release

End of content

No more pages to load

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Shroom Stocks and Companies

News & Interviews

Data Bank

Get in Touch

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Contact Disclaimer Terms of Service Privacy Policy Twitter

© Psilocybin Alpha 2020